Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells
1999
Targeted Drug Delivery for Colon Cancer
publication
Evidence: moderate
Author Information
Author(s): Koning G A, Gorter A, Scherphof G L, Kamps J A A M
Primary Institution: Groningen Institute for Drug Studies
Hypothesis
Immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate can effectively inhibit the growth of colon cancer cells.
Conclusion
The study demonstrates that immunoliposomes can deliver the active drug FUdR to colon carcinoma cells efficiently.
Supporting Evidence
- Immunoliposomes caused a 13-fold stronger inhibition of CC531 cell growth compared to non-targeted liposomes.
- Shorter treatment times with immunoliposomes showed anti-tumor activities comparable to free FUdR.
Takeaway
This study shows that special drug carriers can help deliver cancer medicine directly to tumor cells, making it work better.
Methodology
The study investigated the effects of immunoliposomes on CC531 colon adenocarcinoma cells over a 72-hour treatment period.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website